Case Report: The First Case of Paradoxical Skin Lesions Induced by Xeligekimab in a Patient With SAPHO Syndrome.

Jinlixi (xeligekimab) - Genrix Bio

Case Report: The First Case of Paradoxical Skin Lesions Induced by Xeligekimab in a Patient With SAPHO Syndrome. (PubMed, Int J Rheum Dis) - Apr 14, 2026 - No abstract available
Journal

http://www.ncbi.nlm.nih.gov/pubmed/41974634

Chen Li; Fanzhang Meng; Jianglin Zhang; Li Chang; Shuli Li

Apr 14, 2026